Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Catenin beta-like protein 1 (CTNNBL1) is an evolutionarily conserved nuclear protein distinguished by its armadillo-repeat (ARM) motif-containing central domain, flanked by unique non-ARM structures[1][2][4]. CTNNBL1 functions primarily as a selective nuclear localization signal (NLS)-binding protein that interacts with spliceosomal components (such as CDC5L and Prp31) and with the antibody-diversification enzyme activation-induced cytidine deaminase (AID), thus participating in RNA splicing and immunoglobulin gene diversification[1][2][4][5]. The structure of CTNNBL1 includes a modified ARM domain and additional unique domains, forming a restrictive protein-binding groove. Its interaction with AID is critical for nuclear import and subnuclear localization of AID, thereby influencing somatic hypermutation and class switch recombination in B lymphocytes[1][2][5]. CTNNBL1 is not a classical drug target such as a receptor, enzyme, transporter, or transcription factor, but serves as an important nuclear protein involved in intranuclear transport and nucleic acid processing complexes[1][2][4][5]. There are currently no approved drugs or direct therapeutic modulators targeting CTNNBL1.
Not applicable (no known drugs targeting this protein)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Catenin beta-like protein 1 (CTNNBL1).